A single subcutaneous administration of a sustained-release ivermectin suspension eliminates Psoroptes cuniculi infection in a rabbit farm

被引:3
|
作者
Lu, Mengmeng [1 ,2 ]
Cai, Yunpeng [1 ]
Yang, Shizhuang [1 ]
Wan, Qiang [1 ]
Pan, Baoliang [1 ]
机构
[1] China Agr Univ, Coll Vet Med, Beijing, Peoples R China
[2] Henan Univ, Pharmaceut Coll, Lab Canc Biomarkers & Liquid Biopsy, Kaifeng, Henan, Peoples R China
基金
比尔及梅琳达.盖茨基金会;
关键词
Ivermectin suspension; subcutaneous; Psoroptes cuniculi; pharmacodynamics; solid dispersion; MANGE MITE; SPOT-ON; EFFICACY; INFESTATION; FORMULATION; DORAMECTIN; SELAMECTIN; INJECTION; MICROPARTICLES; DELIVERY;
D O I
10.1080/03639045.2018.1506474
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Psoroptes cuniculi mites are the most common ear parasites infesting breeding female rabbits. The suffering rabbits show cutaneous signs of the infestation in the ears and are prone to secondary infections. Objectives: This trial was conducted to eliminate P. cuniculi in farm rabbits with a sustained-release ivermectin-loaded solid dispersion suspension (IVM-SD) suspension, and studied the stability of the formulation. Animals: There were 986 breeding female Hyplus rabbits naturally infected with P. cuniculi. Methods: All rabbits infected with P. cuniculi were subcutaneously administered with a single dose of IVM-SD suspension at 2 mg/kg body weight. Twenty-seven rabbits with severe infections were observed daily and examined on days 0 and 14 to score the lesions and count mites in crusts. Results: Fourteen days after the treatment no live mites were detected, demonstrating 100% therapeutic efficacy. The mean lesion scores decreased from 4.33 to 0.11 in the left ears and from 4.22 to 0.22 in the right ears. No reinfection occurred within 60 days of treatment. Conclusions: A single subcutaneous administration of the IVM-SD suspension at 2 mg/kg was effective in eliminating P. cuniculi infection in the rabbit farm.
引用
收藏
页码:2000 / 2004
页数:5
相关论文
共 40 条
  • [31] Single-dose intramuscular administration of sustained-release Angiopeptin reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model
    Hong, MK
    Kent, KM
    Tio, FO
    Foegh, M
    Kornowski, R
    Bramwell, O
    Cathapermal, SS
    Leon, MB
    CORONARY ARTERY DISEASE, 1997, 8 (02) : 101 - 104
  • [32] BIOAVAILABILITY OF A NEW SUSTAINED-RELEASE PREPARATION OF VALPROIC ACID UNDER STEADY-STATE CONDITIONS - COMPARISON OF A SINGLE DAILY ADMINISTRATION WITH A TWICE DAILY ADMINISTRATION OF CONVENTIONAL DEPAKINE
    HOUIN, G
    MONTASTRUC, JL
    AUBERT, D
    CAUTREELS
    GOLDBERGER, E
    MORRE, M
    PICARDFRAIRE, C
    SINDELY, L
    ACTA NEUROLOGICA SCANDINAVICA, 1984, 70 (03): : 224 - 224
  • [33] PHARMACOKINETICS OF ACIPIMOX AND OF ITS N-DEOXY METABOLITE FOLLOWING SINGLE AND REPEATED ORAL-ADMINISTRATION OF A SUSTAINED-RELEASE FORMULATION TO HEALTHY-VOLUNTEERS
    EFTHYMIOPOULOS, C
    EDWARDS, DMF
    STROLINBENEDETTI, M
    RUFF, F
    ADVENIER, C
    BIANCHINI, R
    MUSATTI, L
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 95 (1-3) : 127 - 133
  • [34] Duration of Effect of a Single Intravitreal Injection of a Sustained-Release Formulation of Abicipar Pegol Compared to a Bolus Dose of Aflibercept in a Rabbit Model of Persistent Retinal Vascular Leak
    Lutz, David
    Tian, Mingting
    Hernandez, Lisa
    Shen, Hong
    Kulkarni, Ashutosh
    Rivers, Hongwen
    Rodrigues, Gerry
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [35] SIMULTANEOUS MODELING OF MEXILETINE AND HYDROXY-METHYL-MEXILETINE DATA AFTER SINGLE-DOSE AND MULTIPLE-DOSE ADMINISTRATION OF A SUSTAINED-RELEASE MEXILETINE FORMULATION
    BRUNO, R
    SANTONI, Y
    ILIADIS, A
    DJIANE, P
    SERRADIMIGNI, A
    CANO, JP
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1992, 13 (07) : 481 - 493
  • [36] Evaluation of the thermal antinociceptive effects of subcutaneous administration of butorphanol tartrate or butorphanol tartrate in a sustained-release poloxamer 407 gel formulation to orange-winged Amazon parrots (Amazona amazonica)
    Laniesse, Delphine
    Guzman, David Sanchez-Migallon
    Smith, Dale A.
    Douglas, Amie M.
    Mosley, Cornelia
    Beaufrere, Hugues
    Paul-Murphy, Joanne
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2020, 81 (07) : 543 - 550
  • [37] A SINGLE-DOSE STUDY OF THE EFFECT OF FOOD INGESTION AND TIMING OF DOSE ADMINISTRATION ON THE PHARMACOKINETIC PROFILE OF 30-MG SUSTAINED-RELEASE MORPHINE-SULFATE TABLETS
    KAIKO, R
    GRANDY, R
    THOMAS, G
    GOLDENHEIM, P
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 47 (05): : 869 - 878
  • [38] INVESTIGATIONS INTO THE RELATIVE BIOAVAILABILITY OF CARBAMAZEPINE AFTER SINGLE ORAL-ADMINISTRATION OF 3 TEST BATCHES OF A CARBAMAZEPINE-CONTAINING SUSTAINED-RELEASE FORMULATION IN HEALTHY-SUBJECTS
    SCHULZ, HU
    DUSING, R
    GRUNWALD, F
    CZAJA, J
    LUHRMANN, B
    FRECKS, HJ
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (04) : 139 - 144
  • [39] INHIBITION OF THE PITUITARY-GONADAL AXIS BY A SINGLE INTRAMUSCULAR ADMINISTRATION OF D-TRP-6-LH-RH (DECAPEPTYL) IN A SUSTAINED-RELEASE FORMULATION IN PATIENTS WITH PROSTATIC-CARCINOMA
    GONZALEZBARCENA, D
    PEREZSANCHEZ, PL
    GRAEF, A
    GOMEZ, AM
    BEREA, H
    COMARUSCHALLY, AM
    SCHALLY, AV
    PROSTATE, 1989, 14 (04): : 291 - 300
  • [40] SELECTIVE ACCUMULATION OF 3',5'-DIOCTANOYL-5-FLUORO-2'-DEOXYURIDINE (FDURD-C8) AND SUSTAINED-RELEASE OF ITS ACTIVE METABOLITES IN VX-2 RABBIT HEPATOMA FOLLOWING INTRAARTERIAL ADMINISTRATION OF FDURD-C8 SOLUTION IN LIPIODOL
    KAWAGUCHI, T
    FUKUSHIMA, S
    HAYASHI, Y
    KANEKO, M
    NAKANO, M
    CANCER RESEARCH, 1988, 48 (15) : 4179 - 4183